Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial
- PMID: 26015372
- DOI: 10.1016/j.ejvs.2015.04.002
Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial
Abstract
Background: Despite the increasing use of pre- and post-hydration protocols and low osmolar instead of high osmolar iodine containing contrast media, the incidence of contrast induced nephropathy (CIN) is still significant. There is evidence that contrast media cause ischemia reperfusion injury of the renal medulla. Remote ischemic preconditioning (RIPC) is a non-invasive, safe, and low cost method to reduce ischemia reperfusion injury. The aim of this study is to investigate whether RIPC, as an adjunct to standard preventive measures, reduces contrast induced acute kidney injury in patients at risk of CIN.
Methods: The RIPCIN study is a multicenter, single blinded, randomized controlled trial in which 76 patients at risk of CIN received standard hydration combined with RIPC or hydration with sham preconditioning. RIPC was applied by four cycles of 5 min ischemia and 5 min reperfusion of the forearm. The primary outcome measure was the change in serum creatinine from baseline to 48 to 72 hours after contrast administration.
Results: With regard to the primary endpoint, no significant effect of RIPC was found. CIN occurred in four patients (2 sham and 2 RIPC). A pre-defined subgroup analysis of patients with a Mehran risk score ≥11, showed a significantly reduced change in serum creatinine from baseline to 48 to 72 hours in patients allocated to the RIPC group (Δ creatinine -3.3 ± 9.8 μmol/L) compared with the sham group (Δ creatinine +17.8 ± 20.1 μmol/L).
Conclusion: RIPC, as an adjunct to standard preventive measures, does not improve serum creatinine levels after contrast administration in patients at risk of CIN according to the Dutch guideline. However, the present data indicate that RIPC might have beneficial effects in patients at a high or very high risk of CIN (Mehran score ≥ 11). The RIPCIN study is registered at: http://www.controlled-trials.com/ISRCTN76496973.
Keywords: Acute kidney injury – pre- and post-hydration; Contrast induced nephropathy; Randomized controlled trial; Remote ischemic preconditioning.
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Commentary on 'Remote Ischemic Preconditioning to Reduce Contrast Induced Nephropathy: A Randomized Controlled Trial'.Eur J Vasc Endovasc Surg. 2015 Oct;50(4):533. doi: 10.1016/j.ejvs.2015.05.001. Epub 2015 Jun 6. Eur J Vasc Endovasc Surg. 2015. PMID: 26059198 No abstract available.
-
Re. 'Remote Ischemic Preconditioning to Reduce Contrast-Induced Nephropathy: a Randomized Controlled Trial'.Eur J Vasc Endovasc Surg. 2015 Oct;50(4):540. doi: 10.1016/j.ejvs.2015.06.076. Epub 2015 Jul 15. Eur J Vasc Endovasc Surg. 2015. PMID: 26188718 No abstract available.
-
Response to "Re: Remote Ischemic Preconditioning to Reduce Contrast-induced Nephropathy: A Randomized Controlled Trial".Eur J Vasc Endovasc Surg. 2015 Oct;50(4):540-1. doi: 10.1016/j.ejvs.2015.06.026. Epub 2015 Jul 22. Eur J Vasc Endovasc Surg. 2015. PMID: 26210794 No abstract available.
Similar articles
-
Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trial.Trials. 2014 Apr 11;15:119. doi: 10.1186/1745-6215-15-119. Trials. 2014. PMID: 24721127 Free PMC article. Clinical Trial.
-
Remote ischemic preconditioning for prevention of contrast-induced nephropathy - A randomized control trial.Indian Heart J. 2020 Jul-Aug;72(4):244-247. doi: 10.1016/j.ihj.2020.04.010. Epub 2020 May 26. Indian Heart J. 2020. PMID: 32861377 Free PMC article. Clinical Trial.
-
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).Circulation. 2012 Jul 17;126(3):296-303. doi: 10.1161/CIRCULATIONAHA.112.096370. Epub 2012 Jun 26. Circulation. 2012. PMID: 22735306 Clinical Trial.
-
Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects.Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F319-F328. doi: 10.1152/ajprenal.00130.2017. Epub 2017 May 31. Am J Physiol Renal Physiol. 2018. PMID: 28566501 Review.
-
Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.Catheter Cardiovasc Interv. 2020 Nov;96(6):1200-1212. doi: 10.1002/ccd.28709. Epub 2020 Jan 8. Catheter Cardiovasc Interv. 2020. PMID: 31912996
Cited by
-
The efficacy of remote ischemic conditioning in preventing contrast-induced nephropathy among patients undergoing coronary angiography or intervention: An updated systematic review and meta-analysis.Ann Noninvasive Electrocardiol. 2020 Mar;25(2):e12706. doi: 10.1111/anec.12706. Epub 2019 Oct 11. Ann Noninvasive Electrocardiol. 2020. PMID: 31605431 Free PMC article.
-
Non-invasive remote ischemic preconditioning for patients with heart failure undergoing cardiac catheterization: a network meta-analysis of randomized controlled trials.J Cardiothorac Surg. 2024 Oct 1;19(1):573. doi: 10.1186/s13019-024-03082-2. J Cardiothorac Surg. 2024. PMID: 39354636 Free PMC article.
-
Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies.J Clin Med. 2020 Jun 2;9(6):1704. doi: 10.3390/jcm9061704. J Clin Med. 2020. PMID: 32498340 Free PMC article. Review.
-
Limb ischemic preconditioning ameliorates renal microcirculation through activation of PI3K/Akt/eNOS signaling pathway after acute kidney injury.Eur J Med Res. 2020 Mar 19;25(1):10. doi: 10.1186/s40001-020-00407-4. Eur J Med Res. 2020. PMID: 32192513 Free PMC article.
-
Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention.PLoS One. 2016 Oct 10;11(10):e0164256. doi: 10.1371/journal.pone.0164256. eCollection 2016. PLoS One. 2016. PMID: 27723839 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources